Northrop Grumman heads into Monday's Q2 print having surrendered most of the gains flagged in last week's note, with the stock back at $521.57 after falling 3.3% on the week — a sharp reversal from the $549 close that briefly looked like a genuine recovery.
The analyst backdrop has deteriorated further since the previous article. Goldman Sachs cut its price target to $533 on July 14, down from $603, while TD Cowen trimmed to $580 from $680 a day earlier — both maintaining neutral-equivalent ratings. Those moves follow a string of cuts going back through Citigroup, Jefferies, and Morgan Stanley over the past quarter. Every firm that has acted has kept a positive rating, but the consensus target has now drifted to roughly $670, implying about 28% upside from current levels. The gap is wide, but it has been built by targets chasing the stock down rather than by conviction that NOC is materially undervalued. Goldman's new target of $533 sits barely above the current price, underlining just how compressed the near-term bull case has become among the less-convinced holders.
The bull case centres on structural defence spending growth — B-21 production ramp, autonomous systems, space programmes, and growing international demand. Bears are focused on execution: F/A-XX and CCA contract risks remain unresolved, and elevated capital expenditure continues to constrain free cash flow generation. That tension is visible in the factor scores, where EPS momentum ranks in just the 30th percentile over both 30- and 90-day windows, and forward earnings estimates are barely moving — 12-month forward EPS growth ranks in the 2nd percentile of the universe. The stock's P/E has compressed to roughly 17.8x, down more than one full turn over the past month, as the market reprices execution risk ahead of the release.
The short market remains a non-story. SI holds at 1.6% of the free float — still too low to carry narrative weight — and borrow availability is effectively uncapped, with over 121 million shares available against a short position of around 2.3 million. Options positioning is almost exactly in line with the recent average, with the put/call ratio at 0.98 against a 20-day mean of 0.97, suggesting no unusual hedging pressure building ahead of the event. On past earnings reactions, the Q1 2026 print produced a one-day drop of around 10% and a five-day loss of roughly 12% — the sharpest post-earnings move in the recent history. The more modest reactions at subsequent events (-0.9% and -2.5%) suggest that particular print was an outlier, though the memory of it is likely shaping how cautiously the Street is positioned now.
Monday's report is therefore a test of whether NOC can arrest the target-cut cycle — delivering enough on margins and programme milestones to give the remaining bulls reason to stop lowering the bar.
See the live data behind this article on ORTEX.
Open NOC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
